Papers - MAKIGUCHI Tomonori
-
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49 %): TOPGAN2023-01.
Tanaka H, Makiguchi T, Tozuka T, Kawashima Y, Oba T, Tsugitomi R, Koyama J, Tambo Y, Ogusu S, Saiki M, Gyotoku H, Hasegawa T, Miyauchi E, Sonoda T, Saito R, Nakatomi K, Sakatani T, Kudo K, Tsuchiya-Kawano Y, Nishio M.
Eur J Cancer. 2024.12
-
Highly sensitive and accurate detection of ALK-TKI resistance mutations by oligoribonucleotide interference-PCR (ORNi-PCR)-based methods.
Tabe C, Fujita T, Taima K, Tanaka H, Makiguchi T, Itoga M, Ishioka Y, Tasaka S, Fujii H.
Lung Cancer. 197 2024.11
-
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.
Mouri A, Kisohara A, Morita R, Ko R, Nakagawa T, Makiguchi T, Isobe K, Ishikawa N, Kondo T, Akiyama M, Bessho A, Honda R, Yoshimura K, Kagamu H, Kato S, Kobayashi K, Kaira K, Maemondo M.
ESMO Open. 2024.10
-
Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias.
Ishidoya M, Makiguchi T, Tanaka H, Miura T, Nunomura Y, Miura D, Morimoto T, Hasegawa Y, Taima K, Tasaka S
Lung cancer (Amsterdam, Netherlands) 192 107790 2024.6
-
Role of G-protein-coupled estrogen receptor in the pathogenesis of chronic asthma.
Itoga M, Ishioka Y, Makiguchi T, Tanaka H, Taima K, Saito N, Tomita H, Tasaka S.
Immunol Lett 2024.2
-
Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: A prospective pilot study.
Makiguchi T, Tanaka H, Okudera K, Taima K, Tasaka S.
Transl Lung Cancer Res. 2023.4
-
Granulomatosis with Polyangiitis following COVID-19 in an Adolescent.
Nakamura Y, Okumura F, Nihei M, Chubachi K, Sakamoto H, Ishioka Y, Makiguchi T, Tanaka H, Taima K, Yajima N, Kurose A, Tasaka S.
Intern Med. 62 ( 4 ) 589 - 593 2023.2
-
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Tanaka H, Tanzawa S, Misumi T, Makiguchi T, Inaba M, Honda T, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Fukuda Y, Yasugi M, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Shiraishi K, Matsutani N, Seki N.
Ther Adv Med Oncol. 14 2022.12
-
Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series.
Ishioka Y, Makiguchi T, Itoga M, Tanaka H, Taima K, Goto S, Tasaka S
Chest 162 ( 6 ) e311 - e316 2022.12
-
クライオバイオプシーで診断した肺クリプトコックス症の1例．
小田切 遥, 牧口 友紀, 福島 高志, 石岡 佳子, 糸賀 正道, 田中 寿志, 當麻 景章, 田坂 定智．
気管支学（日本呼吸器内視鏡学会雑誌) 44 ( 5 ) 325 - 330 2022.9
-
Feasibility and safety of platinum-doublet therapy in patients with small-cell lung cancer in the third-line setting: A multi-institutional retrospective study.
Fukushima T, Makiguchi T, Tanaka Y, Chubachi K, Ishidoya M, Suzuki S, Tanaka H, Taima K, Hasegawa Y, Okudera K, Tasaka S.
Oncol Lett. 24 ( 4 ) 368 2022.9
-
HER2遺伝子変異陽性肺癌に対して化学放射線療法後にデュルバルマブを投与した1例．
佐々木悠子，田中寿志，牧口友紀，小堀由璃，小田切遥，田坂定智．
日本呼吸器学会誌 11(5) 310 - 314 2022.9
-
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N.
Ther Adv Med Oncol 14 2022.7
-
Diabetic ketoacidosis shortly after COVID-19 vaccination in a non–small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: A case report.
Makiguchi T, Tanaka H, Taima K, Takayasu S, Tasaka S
Thorac Cancer 13 ( 8 ) 1220 - 1223 2022.4
-
Diabetic ketoacidosis shortly after COVID-19 vaccination in a non–small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: A case report
2022.2
-
健診異常で肺野に単発の結節影を指摘された患者が受診されました．どうすればよいでしょうか？
牧口友紀，田坂定智
内科 130 370 - 371 2022
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Makiguchi T, Tanaka H, Kamata K, Taima K, Kurose A, Tasaka S
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.10
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Tomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, Kageaki Taima, Akira Kurose, Sadatomo Tasaka
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.8
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients
2021.7
-
脳神経の経時的画像所見を追跡できた完全型 Heerfordt 症候群の1 例
牧口友紀，小林誠一，豊嶋昌弥，小野祥直，小野 学，矢内 勝
日呼吸誌 2021.3